Important Innovations

  Sanifit Creating Biotech Treatments For Untreatable Disease                                                Source: Stock Biopharma Image Biomedical Innovation from Spain The European Investment Bank (EIB) is providing Spain-based biopharmaceutical company Sanifit 20 million euros, on top of the $130 million the company has already raised, to bring to market new, innovative treatments for vascular calcification. This is an area of unmet medical need where there are no treatments.  Sanifit is in Phase 3 trials with what appears to be an effective remedy against this deadly disease. Novel, Innovative Treatments  Sanifit's treatments are targeted against two disease indicators of progressive vascular calcification.  The company has developed SNF472, a potent inhibitor of hydroxyapatite (HAP) crystallization which is the final step to vascular calcification.  The treatment is moving through Phase 3 trials for calciphylaxis, a devastating disease which blocks small blood vessels and re

Promising Oxford University Vaccine Source:  Gilead Sciences Successful Gilead Sciences Treatment In the war against COVID-19, some good news.  Gilead Sciences' remdesivir has shown improvement in patients taking it to treat the virus. That, according to Gilead's own study.  On top of that, testing by the National Institution of Allergy and Infectious Disease also gave the drug "positive data" results in their own testing.  This news raised hopes on Wall Street that a treatment/cure is near and that the economy may be able to open safely again.  At the start of trading, the DJIA shot up 400 points and Gilead shares were up 9.3%. Promising Vaccine Meanwhile, researchers at Oxford University in the UK say they could  have a COVID-19 vaccine ready for humans by the 4th quarter of this year. Their experimental vaccine has proven effective in protecting monkeys from the virus.  Monkeys given the vaccin

Stop Gap Covid-19 Treatment Source:  DARPA Race to Stop COVID-19 in its Tracks The US Defense Department's Advanced Research Projects Agency - DARPA - has been given the green light to fast track "mission critical" programs to fight and defeat the coronavirus,  which has infected nearly 1 million Americans.  DARPA is a global epicenter of breakthrough innovation. It has created the internet, Artificial Intelligence, cloud computing and  much more. Unique Stop Gap Therapy in the Pipeline Right now, DARPA is working on a therapy - what they're calling a "firewall" - that would temporarily  protect someone from contracting the disease.  It is a stop-gap therapy for use before a vaccine is created, which is expected sometime in 2021 at the earliest. Firewall P3 Platform DARPA wants their P3 Platform therapy  to work immediately in the patient and last for six months.  DARPA has identifi

Chinese Scientists Developing Promising Treatment Source:  Stock image of coronavirus "Extremely Effective" Antibodies Discovered to Fight the Disease A team of Chinese scientists at Tsinghau University in Beijing have isolated several antibodies that are "extremely effective" at blocking the coronavirus from entering cells.  They believe they may be on the right track for treating and even preventing the disease.  Globally, more than 850,000 have been infected by COVID-19 and 42,000 have died.  To date, there is no known, effective and proven treatment for the disease which originated in Wuhan, China Next Steps to Mass Production The team analyzed blood from patients who recovered from the coronavirus.  They pinpointed 206  antibodies with a strong  ability to bind with the virus' protein. Of that group 4 antibodies blocked the virus from entering cells and two are exceedingly effective at doing that.  The Chinese scientists are now work